CA, C., P, A., CC, A., PF, M., T, T., LW, D., . . . JE, H. (2020). Maternal dexamethasone before preterm births: Implications for lower middle-income countries - Authors' reply. The Lancet. Child & adolescent health, 4(1), e2. https://doi.org/10.1016/S2352-4642(19)30389-X
Chicago Style (17th ed.) CitationCA, Crowther, Ashwood P, Andersen CC, Middleton PF, Tran T, Doyle LW, Robinson JS, and Harding JE. "Maternal Dexamethasone Before Preterm Births: Implications for Lower Middle-income Countries - Authors' Reply." The Lancet. Child & Adolescent Health 4, no. 1 (2020): e2. https://doi.org/10.1016/S2352-4642(19)30389-X.
MLA (9th ed.) CitationCA, Crowther, et al. "Maternal Dexamethasone Before Preterm Births: Implications for Lower Middle-income Countries - Authors' Reply." The Lancet. Child & Adolescent Health, vol. 4, no. 1, 2020, p. e2, https://doi.org/10.1016/S2352-4642(19)30389-X.